Comparable reductions in hyperpnoea-induced bronchoconstriction and markers of airway inflammation after supplementation with 6·2 and 3·1 g/d of long-chain n-3 PUFA in adults with asthma
Although high dose n-3 PUFA supplementation reduces exercise- and hyperpnoea-induced bronchoconstriction (EIB/HIB), there are concurrent issues with cost, compliance and gastrointestinal discomfort. It is thus pertinent to establish the efficacy of lower n-3 PUFA doses. Eight male adults with asthma...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
Cambridge University Press
2017
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/43614/ |